From longevity clinics to the aesthetic chair
NAD+ (nicotinamide adenine dinucleotide) started as a longevity and metabolic-health conversation, driven by IV therapy clinics and wellness influencers. It has now moved firmly into aesthetic practice, as the line between "anti-ageing" and "skin longevity" continues to blur and patients increasingly view skin as a visible marker of internal cellular health rather than a purely cosmetic concern.
What NAD+ actually does
NAD+ is a coenzyme present in every cell, central to energy metabolism, mitochondrial function and DNA repair. Cellular NAD+ levels decline with age, which is the biological rationale behind interest in restoring them — whether systemically, via IV or oral precursors, or topically for localised skin effects.
Delivery routes, and what each is realistic for
| Route | Typical positioning | What to know |
|---|---|---|
| IV NAD+ | Systemic, longevity/metabolic focus | Bypasses first-pass metabolism; growing interest from weight-management and longevity patients |
| Oral precursors (NMN, NR) | Systemic, convenience-led | Requires conversion to NAD+ in the body; more accessible entry point for patients |
| Topical NAD+ / NMN | Localised skin support | Stabilisation and skin penetration remain genuine formulation challenges; often blended with peptides or PDRN for delivery |
Where the evidence currently stands
- NAD+'s role in cellular energy metabolism and DNA repair is well established in the broader biological literature.
- Skin-specific clinical efficacy data is still preliminary. Much of what is currently marketed sits ahead of large-scale aesthetic trial evidence, similar to where exosomes and polynucleotides were a few years ago.
- Pure NAD+ is genuinely difficult to stabilise for topical use, which is why many current formulations use precursor molecules or liposomal delivery rather than NAD+ itself.
- The strongest current clinical rationale is as part of the broader longevity and metabolic-health conversation, particularly for patients already engaged in weight-management or wellness programmes, rather than as a standalone skin-clearing claim.
Clinical decision framework for offering NAD+
- Which delivery route fits your practice model — IV, oral, topical, or a combination
- Whether NAD+ sits within a broader longevity/wellness service line or as an aesthetic add-on
- Sourcing, stability and characterisation of any topical product before making skin-specific claims
- Staff training to distinguish "supports cellular energy metabolism" (well supported) from specific aesthetic outcome claims (still developing evidence)
- How NAD+ complements — rather than replaces — established regenerative modalities like biostimulators, polynucleotides and exosomes already in your protocol mix
Positioning it honestly to patients
Patients are already hearing about NAD+ from longevity influencers before they reach the consult chair. The clinics earning long-term trust are leading with the well-supported mechanism, being clear that skin-specific outcome data is still developing, and framing NAD+ as one part of a broader cellular-health and skin-longevity conversation rather than a standalone miracle ingredient.
Conclusion
NAD+ is a legitimate and fast-growing area of interest, sitting at the intersection of longevity medicine and aesthetic skin health. The biological rationale is sound; the aesthetic-specific evidence base is still catching up. Treated as part of a broader regenerative and wellness offering — rather than an isolated claim — it is one of the more defensible ways to meet where patient interest already is in 2026.